drugset / Trial / NCT00024362

BBR 3464 in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer That Cannot be Treated With Surgery

NCT00024362 ↗

Phase 2 Unknown Theradex
Treatment

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of BBR 3464 in treating patients who have locally advanced or metastatic pancreatic cancer that cannot be treated with surgery.

Timeline

Start
2001-05
Primary completion
—
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject TRIPLATIN TETRANITRATE Small molecule — Intravenous